Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Infectious Disease Reports
Erschienen in: Current Infectious Disease Reports 2/2013

01.04.2013 | GENITOURINARY INFECTIONS (J SOBEL, SECTION EDITOR)

Genetic Basis for Recurrent Vulvo-Vaginal Candidiasis

verfasst von: Martin Jaeger, Theo S. Plantinga, Leo A. B. Joosten, Bart-Jan Kullberg, Mihai G. Netea

Erschienen in: Current Infectious Disease Reports | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Vulvovaginal candidiasis (VVC) is a frequent disease affecting more than 75% of all women at least once in their lifetime. Up to 8% of them suffer from recurrent VVC (RVVC) characterized by at least three episodes each year. Several risk factors, such as antibiotic use, diabetes, or pregnancy, are known, but the vast majority of women with RVVC develop the infection without having any risk factor, implying that a genetic component most likely plays an important role in the susceptibility to RVVC. This review summarizes the immunogenetic alterations that lead to an increased susceptibility to vaginal infections with Candida albicans. Different mutations and polymorphisms in innate immune genes alter the mucosal immune response against fungi and are likely to have an important role in susceptibility to RVVC. A better understanding of the genetic and immunological mechanisms leading to RVVC is important for both the understanding of the pathophysiology of the disease and the design of novel therapeutic strategies.
Literatur
1.
2.
Sobel JD. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol. 1985;152(7 Pt 2):924–35.PubMed
3.
4.
Sobel JD. Pathogenesis and epidemiology of vulvovaginal candidiasis. Ann N Y Acad Sci. 1988;544:547–57.PubMedCrossRef
5.
Sobel JD. Pathogenesis and treatment of recurrent vulvovaginal candidiasis. Clin Infect Dis. 1992;14 Suppl 1:S148–53.PubMedCrossRef
6.
Fidel Jr PL. History and update on host defense against vaginal candidiasis. Am J Reprod Immunol. 2007;57(1):2–12.PubMedCrossRef
7.
Cassone A, De Bernardis F, Santoni G. Anticandidal immunity and vaginitis: novel opportunities for immune intervention. Infect Immun. 2007;75(10):4675–86.PubMedCrossRef
8.
Kent HL. Epidemiology of vaginitis. Am J Obstet Gynecol. 1991;165(4 Pt 2):1168–76.PubMed
9.
Milsom I, Forssman L. Repeated candidiasis: reinfection or recrudescence? A review. Am J Obstet Gynecol. 1985;152(7 Pt 2):956–9.PubMed
10.
Nawrot U et al. The study of cell-mediated immune response in recurrent vulvovaginal candidiasis. FEMS Immunol Med Microbiol. 2000;29(2):89–94.PubMedCrossRef
11.
12.
Fidel Jr PL, Sobel JD. Immunopathogenesis of recurrent vulvovaginal candidiasis. Clin Microbiol Rev. 1996;9(3):335–48.PubMed
13.
Steele C, Fidel PL. Cytokine and chemokine production by human oral and vaginal epithelial cells in response to Candida albicans. Infect Immun. 2002;70(2):577–83.PubMedCrossRef
14.
Weindl G et al. Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling. J Clin Invest. 2007;117(12):3664–72.PubMed
15.
Hornef MW, Bogdan C. The role of epithelial Toll-like receptor expression in host defense and microbial tolerance. J Endotoxin Res. 2005;11(2):124–8.PubMed
16.
Yano J et al. Epithelial cell-derived S100 calcium-binding proteins as key mediators in the hallmark acute neutrophil response during Candida vaginitis. Infect Immun. 2010;78(12):5126–37.PubMedCrossRef
17.
Naglik JR et al. Candida albicans interactions with epithelial cells and mucosal immunity. Microbes Infect. 2011;13(12–13):963–76.PubMedCrossRef
18.
Barousse MM et al. Growth inhibition of Candida albicans by human vaginal epithelial cells. J Infect Dis. 2001;184(11):1489–93.PubMedCrossRef
19.
Steele C et al. Growth inhibition of Candida by human oral epithelial cells. J Infect Dis. 2000;182(5):1479–85.PubMedCrossRef
20.
Steele C et al. Growth inhibition of Candida albicans by vaginal cells from naive mice. Med Mycol. 1999;37(4):251–9.PubMed
21.
Barousse MM et al. Vaginal epithelial cell anti-Candida albicans activity is associated with protection against symptomatic vaginal candidiasis. Infect Immun. 2005;73(11):7765–7.PubMedCrossRef
22.
Netea MG et al. An integrated model of the recognition of Candida albicans by the innate immune system. Nat Rev Microbiol. 2008;6(1):67–78.PubMedCrossRef
23.
Brown GD, Gordon S. Immune recognition of fungal beta-glucans. Cell Microbiol. 2005;7(4):471–9.PubMedCrossRef
24.
Eisen DP, Minchinton RM. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis. 2003;37(11):1496–505.PubMedCrossRef
25.
Chaim W, Foxman B, Sobel JD. Association of recurrent vaginal candidiasis and secretory ABO and Lewis phenotype. J Infect Dis. 1997;176(3):828–30.PubMedCrossRef
26.
•• Ferwerda B et al. Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med. 2009;361(18):1760–7. This study showed that a mutaion in the β-glucan receptor dectin-1 lead to a defect in the antifungal defense. Reduced receptor expression and ligand binding, as well as decreased cytokine (IL-17,IL-6, and TNF-α), are the consequences of this mutation.PubMedCrossRef
27.
Rosentul DC et al. Genetic variation in the dectin-1/CARD9 recognition pathway and susceptibility to candidemia. J Infect Dis. 2011;204(7):1138–45.PubMedCrossRef
28.
Filler SG. Insights from human studies into the host defense against candidiasis. Cytokine. 2012;58(1):129–32.PubMedCrossRef
29.
Taylor PR et al. Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat Immunol. 2007;8(1):31–8.PubMedCrossRef
30.
Gow NA et al. Immune recognition of Candida albicans beta-glucan by dectin-1. J Infect Dis. 2007;196(10):1565–71.PubMedCrossRef
31.
•• Glocker EO et al. A Homozygous CARD9 Mutation in a Family with Susceptibility to Fungal Infections. N Engl J Med. 2009;361(18):1727–35. This study showed that homozygous mutations in the intracellular adapter molecule CARD9 lead to an increased susceptibility to fungal infections. CARD9 signals downstream to dectin-1, a receptor with great importance in the fungal defense.PubMedCrossRef
32.
Glocker EO et al. Susceptibility to fungal infections due to a homozygous mutation in CARD9. Clin Exp Immunol. 2010;160:4–5.
33.
Plantinga TS et al. Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2009;49(5):724–32.PubMedCrossRef
34.
Gross O et al. Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature. 2006;442(7103):651–6.PubMedCrossRef
35.
LeibundGut-Landmann S et al. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol. 2007;8(6):630–8.PubMedCrossRef
36.
Sutterwala FS, Ogura Y, Flavell RA. The inflammasome in pathogen recognition and inflammation. J Leukoc Biol. 2007;82(2):259–64.PubMedCrossRef
37.
• Lev-Sagie A et al. Polymorphism in a gene coding for the inflammasome component NALP3 and recurrent vulvovaginal candidiasis in women with vulvar vestibulitis syndrome. Am J Obstet Gynecol. 2009;200(3):303 e1–6. This research article showed that inflammasome-mediated IL-1β production was decreased in women with polymorpisms in the CIAS1 gene. Women postive for the risk allele were more frequently found in VVC and RVVC cohorts.CrossRef
38.
Omi T et al. An intronic variable number of tandem repeat polymorphisms of the cold-induced autoinflammatory syndrome 1 (CIAS1) gene modifies gene expression and is associated with essential hypertension. Eur J Hum Genet. 2006;14(12):1295–305.PubMedCrossRef
39.
Babula O et al. Relation between recurrent vulvovaginal candidiasis, vaginal concentrations of mannose-binding lectin, and a mannose-binding lectin gene polymorphism in Latvian women. Clin Infect Dis. 2003;37(5):733–7.PubMedCrossRef
40.
Kilpatrick DC. Mannan-binding lectin and its role in innate immunity. Transfus Med. 2002;12(6):335–52.PubMedCrossRef
41.
Turner MW. The role of mannose-binding lectin in health and disease. Mol Immunol. 2003;40(7):423–9.PubMedCrossRef
42.
Herpers BL et al. Acute-phase responsiveness of mannose-binding lectin in community-acquired pneumonia is highly dependent upon MBL2 genotypes. Clin Exp Immunol. 2009;156(3):488–94.PubMedCrossRef
43.
Babovic-Vuksanovic D, Snow K, Ten RM. Mannose-binding lectin (MBL) deficiency. Variant alleles in a midwestern population of the United States. Ann Allergy Asthma Immunol. 1999;82(2):134–8. 141; quiz 142-3.PubMedCrossRef
44.
Milanese M et al. MBL2 genetic screening in patients with recurrent vaginal infections. Am J Reprod Immunol. 2008;59(2):146–51.PubMedCrossRef
45.
• Donders GG et al. Mannose-binding lectin gene polymorphism and resistance to therapy in women with recurrent vulvovaginal candidiasis. BJOG. 2008;115(10):1225–31. This article confirms the previous hypothesis that the MBL2 polymorphism in codon 54 is more frequently found in women with RVVC. The result of this polymorphism is reduced levels of MBL.PubMedCrossRef
46.
Liu F, Liao Q, Liu Z. Mannose-binding lectin and vulvovaginal candidiasis. Int J Gynaecol Obstet. 2006;92(1):43–7.PubMedCrossRef
47.
Giraldo PC et al. Mannose-binding lectin gene polymorphism, vulvovaginal candidiasis, and bacterial vaginosis. Obstet Gynecol. 2007;109(5):1123–8.PubMedCrossRef
48.
Wojitani MD et al. Association between mannose-binding lectin and interleukin-1 receptor antagonist gene polymorphisms and recurrent vulvovaginal candidiasis. Arch Gynecol Obstet. 2012;285(1):149–53.PubMedCrossRef
49.
Wink DA et al. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science. 1991;254(5034):1001–3.PubMedCrossRef
50.
Cenci E et al. Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans. Eur J Immunol. 1993;23(5):1034–8.PubMedCrossRef
51.
Babula O et al. Frequency of interleukin-4 (IL-4) -589 gene polymorphism and vaginal concentrations of IL-4, nitric oxide, and mannose-binding lectin in women with recurrent vulvovaginal candidiasis. Clin Infect Dis. 2005;40(9):1258–62.PubMedCrossRef
52.
Sampaio P et al. Highly polymorphic microsatellite for identification of Candida albicans strains. J Clin Microbiol. 2003;41(2):552–7.PubMedCrossRef
53.
Sampaio P et al. New microsatellite multiplex PCR for Candida albicans strain typing reveals microevolutionary changes. J Clin Microbiol. 2005;43(8):3869–76.PubMedCrossRef
54.
• Fan SR et al. Genotype distribution of Candida albicans strains associated with different conditions of vulvovaginal candidiasis, as revealed by microsatellite typing. Sex Transm Infect. 2008;84(2):103–6. This study compares different Candida albicans strains in RVVC, as well as in control, cohorts. It is shown that particular C. albicans strains are more frequently present in patients suffering form (R)VVC. This implies a correlation of different C.albicans genotypes and the severity of (R)VVC.PubMedCrossRef
Metadaten
Titel
Genetic Basis for Recurrent Vulvo-Vaginal Candidiasis
verfasst von
Martin Jaeger
Theo S. Plantinga
Leo A. B. Joosten
Bart-Jan Kullberg
Mihai G. Netea
Publikationsdatum
01.04.2013
Verlag
Current Science Inc.
Erschienen in
Current Infectious Disease Reports / Ausgabe 2/2013
Print ISSN: 1523-3847
Elektronische ISSN: 1534-3146
DOI
https://doi.org/10.1007/s11908-013-0319-3

Weitere Artikel der Ausgabe 2/2013

Current Infectious Disease Reports 2/2013 Zur Ausgabe

RESPIRATORY INFECTIONS (F ARNOLD, SECTION EDITOR)

Epidemiologic and Clinical Implications of Second-Generation Pneumococcal Conjugate Vaccines

RESPIRATORY INFECTIONS (F ARNOLD, SECTION EDITOR)

Does an Upper Respiratory Tract Infection During Pregnancy Affect Perinatal Outcomes? A Literature Review

RESPIRATORY INFECTIONS (F ARNOLD, SECTION EDITOR)

Viral Infections in Children with Community-Acquired Pneumonia

Hot Topic

Fecal Bacteriotherapy for Recurrent Clostridium difficile Infection: What’s Old Is New Again?

RESPIRATORY INFECTIONS (F ARNOLD, SECTION EDITOR)

Could Vitamin D Have a Potential Anti-Inflammatory and Anti-Infective Role in Bronchiectasis?

RESPIRATORY INFECTIONS (F ARNOLD, SECTION EDITOR)

Determining the Duration of Therapy for Patients with Community-Acquired Pneumonia

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise